Karnes RJ - Search Results

1

Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients.

Gontero P, Sylvester R, Pisano F, Joniau S, Vander Eeckt K, Serretta V, Larré S, Di Stasi S, Van Rhijn B, Witjes AJ, Grotenhuis AJ, Kiemeney LA, Colombo R, Briganti A, Babjuk M, Malmström PU, Oderda M, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Varkarakis J, Bartoletti R, Spahn M, Johansson R, Frea B, Soukup V, Xylinas E, Dalbagni G, Karnes RJ, Shariat SF, Palou J. Gontero P, et al. Among authors: karnes rj. Eur Urol. 2015 Jan;67(1):74-82. doi: 10.1016/j.eururo.2014.06.040. Epub 2014 Jul 16. Eur Urol. 2015. PMID: 25043942 Free article.

2

A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.

Halling KC, King W, Sokolova IA, Karnes RJ, Meyer RG, Powell EL, Sebo TJ, Cheville JC, Clayton AC, Krajnik KL, Ebert TA, Nelson RE, Burkhardt HM, Ramakumar S, Stewart CS, Pankratz VS, Lieber MM, Blute ML, Zincke H, Seelig SA, Jenkins RB, O'Kane DJ. Halling KC, et al. Among authors: karnes rj. J Urol. 2002 May;167(5):2001-6. J Urol. 2002. PMID: 11956427

3

Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.

Frank I, Cheville JC, Blute ML, Lohse CM, Karnes RJ, Weaver AL, Sebo TJ, Nehra A, Zincke H. Frank I, et al. Among authors: karnes rj. Cancer. 2004 Oct 15;101(8):1803-8. doi: 10.1002/cncr.20567. Cancer. 2004. PMID: 15386300 Free article.

4

Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization.

Kipp BR, Karnes RJ, Brankley SM, Harwood AR, Pankratz VS, Sebo TJ, Blute MM, Lieber MM, Zincke H, Halling KC. Kipp BR, et al. Among authors: karnes rj. J Urol. 2005 Feb;173(2):401-4. doi: 10.1097/01.ju.0000149825.83180.a4. J Urol. 2005. PMID: 15643180 Clinical Trial.

5

Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.

Gillett MD, Cheville JC, Karnes RJ, Lohse CM, Kwon ED, Leibovich BC, Zincke H, Blute ML. Gillett MD, et al. Among authors: karnes rj. J Urol. 2005 Jun;173(6):1893-6. doi: 10.1097/01.ju.0000158157.57981.80. J Urol. 2005. PMID: 15879770

6

Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy.

Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ. Blute ML, et al. Among authors: karnes rj. J Urol. 2007 Aug;178(2):440-5; discussion 444. doi: 10.1016/j.juro.2007.03.121. Epub 2007 Jun 11. J Urol. 2007. PMID: 17561151

7

Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.

Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML. Boorjian SA, et al. Among authors: karnes rj. J Urol. 2007 Sep;178(3 Pt 1):864-70; discussion 870-1. doi: 10.1016/j.juro.2007.05.048. Epub 2007 Jul 16. J Urol. 2007. PMID: 17631342

8

Assessing the value of reflex fluorescence in situ hybridization testing in the diagnosis of bladder cancer when routine urine cytological examination is equivocal.

Kipp BR, Halling KC, Campion MB, Wendel AJ, Karnes RJ, Zhang J, Sebo TJ. Kipp BR, et al. Among authors: karnes rj. J Urol. 2008 Apr;179(4):1296-301; discussion 1301. doi: 10.1016/j.juro.2007.11.082. Epub 2008 Mar 4. J Urol. 2008. PMID: 18289582

9

Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.

Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML. Boorjian SA, et al. Among authors: karnes rj. J Urol. 2008 Apr;179(4):1354-60; discussion 1360-1. doi: 10.1016/j.juro.2007.11.061. Epub 2008 Mar 4. J Urol. 2008. PMID: 18289596

10

Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL.

Inman BA, Davies JD, Rangel LJ, Bergstralh EJ, Kwon ED, Blute ML, Karnes RJ, Leibovich BC. Inman BA, et al. Among authors: karnes rj. Cancer. 2008 Oct 1;113(7):1544-51. doi: 10.1002/cncr.23767. Cancer. 2008. PMID: 18680171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

477 results

Search Page